Sign in

CIK 0001936258

  • Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
Open-market buys, last 90 days
$226,500
in 1 filing
Open-market sales, last 90 days
$4,661,919
in 3 filings, $4.6M under 10b5-1 plans

Net −$4,435,419. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-09-15 Topper James N Director Purchase +660 $23.70 $16K 3,028,524
2025-09-08 Topper James N Director Purchase +1,260 $24.99 $31K 3,027,864
2025-08-11 Topper James N Director Purchase +471 $23.98 $11K 3,026,604
2025-06-25 Topper James N Director Purchase +1,260 $18.26 $23K 3,026,133
2025-06-24 Topper James N Director Purchase +2,520 $18.43 $46K 3,024,873
2025-06-16 Topper James N Director Purchase +8,584 $19.50 $167K 3,022,153
2025-03-26 Topper James N Director Purchase +1,135 $22.49 $26K 3,013,569
2025-03-04 Topper James N Director Purchase +4,005 $21.02 $84K 3,012,434
2024-03-26 Topper James N Director Purchase +8,429 $21.50 $181K 3,008,429

Page 1 of 1 · 9 trades